4th Quarter - Report

TIBER CREEK GROUP for INFUSYSTEMS HOLDINGS, INC.

Firm
Client
Income
$20,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Issue related to Medicare reimbursement for opioid alternative treatments, including the NOPAIN Act, HR 5172/S 3067

LobbyistCovered position, as disclosed
JAMES HEIMBACH —
EMILY KIRLIN —
ANDREW MCKECHNIE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 5172 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.